The Ohio Association of County Behavioral Health Authorities, in partnership with Ohio Mental Health and Addiction Services and the Ohio Department of Rehabilitation and Correction, is proud to present the American Society of Addiction Medicine (ASAM) Treatment of Opioid Use Disorder Course on Monday, June 12, at the Hyatt Regency in Columbus, OH.
This blended course covers treating opioid use disorder by using interactive, case-based learning to teach evidence-based practices. This course is Substance Abuse and Mental Health Services Administration (SAMHSA)-supported and meets the requirements needed to obtain the waiver to prescribe buprenorphine in office-based treatment of opioid use disorders.
- Physicians, nurse practitioners, and physician assistants who wish to obtain a waiver to prescribe buprenorphine in office-based treatment of opioid use disorders
- Clinicians and health care team members working with physicians who prescribe buprenorphine in office-based treatment of opioid use disorders.
- The first half of the course is administered online through 4 hours of independent, self-paced learning, including competency quizzes, which must be successfully completed as part of the process to obtain a waiver
- The second half of the course is delivered by recognized national experts in a 4-hour live classroom setting.
- Apply for a waiver to prescribe buprenorphine to their patients with opioid use disorders
- Identify and assess patients who are appropriate for treatment with medications
- Have specific knowledge concerning the use of medications to manage patients with addiction involving opioid use
- Discuss the psychiatric and medical co-morbidities associated with opioid addiction.
The ASAM is a SAMHSA-supported provider of the 8-hour training for physicians, nurse practitioners, and physician assistants needed to obtain the waiver to prescribe buprenorphine. The ASAM also provides the additional 16 hours that are required for NPs and PAs.
- Provide documentation that they have received a Drug Enforcement Agency waiver to prescribe buprenorphine
- Indicate a willingness to prescribe MAT in their practice setting.